-
Novartis AG et al v. HEC Pharm Co. Ltd. et al DC CAFC
- 1:15-cv-00151
- D. Del.
- Judge: Leonard P. Stark
- Filed: 02/11/2015
- Closed: 06/09/2017
- Latest Docket Entry: 12/26/2017
- PACER
- Docket updated daily
4
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
850
Days in
Litigation
-
Novartis AG et al v. HEC Pharm Co. Ltd. et al DC CAFC
- 1:15-cv-00151
- D. Del.
- Judge: Leonard P. Stark
- Filed: 02/11/2015
- Closed: 06/09/2017
- Latest Docket Entry: 12/26/2017
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
HEC Pharm Company Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 5,604,229 A |
9, 10, 35, 36, 46, 48
|
Infringement
Entry 223
|
HEC Pharm Group
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 5,604,229 A |
9, 10, 35, 36, 46, 48
|
Infringement
Entry 223
|
HEC Pharm USA Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Fingolimod 0.5 mg capsules | US 5,604,229 A |
9, 10, 35, 36, 46, 48
|
Infringement
Entry 223
|
